Dr. Issame Outaleb

Dear Network! I am very delighted and humbled today to partner with Healthcare Shapers. A top tier international network of independent consultants, service providers, experts and decision makers with great breadth and depth of experience in the healthcare industry. Working hand in hand to drive innovation and cutting-edge technologies is our duty! Feel free to reach out in case of questions or request for proposals. Sincerely, Dr. Issame Outaleb

Sep 2018 -Jun 2019 - OPEX/ Digital transformation Lead - AstraZeneca *Smart Tool dev using AI/ML to better predict Asthma and other chronic diseases *Launch Plan audit Fasenra *Business review lead May-Jun2018 Growth Strategies lead – Korian Group -EU leader *Refine core messaging across centers *Enhance multichannel communications and Customer segmentation Jan-Apr 2018 Global Pricing Market Access Strgy &Brand Lead– Shire *Pricing analysis in Hematology *Refine Brand Plans *PM Operations

Blockchain and AI/Machine learning startup enhancing: R&D clinicals outcome, chronic disess patterns, Track and Trace in Supply chain, Data Security, Instant Transactions, managing complexe processing, and Cost Savings within Healthcare and Pharma Ecosystem (B2B)

*Blockchain thought leadership and advisory *Cryptocurrencies Security and Privacy *Peer to Peer / B2B financials

Sep-Dec 2017 Lead- Business & Market intel -Teva Paris *Operations and Business Plan *Market Insights *Process and Sales Optimization// Feb-Jul 2017 PMO Lead Oncology – Pfizer Berlin *Implement growth opps *Medical Strategic Planning and MSL Excellence *Sales Training App dvpmt & integration *Stakeholder Engagement Segmentation// Nov 2016 -Jan 2017 Project lead Biosimilars Oncology & RA –Sandoz *Market launch strategy and planning *Pricing Market access *Go to Market Strategy *KAP

Selbstständige Mitarbeit in und Projektmanagement in internationalen Teams - Fokus der Projektarbeit: Pricing und Market Access (PMA) Strategien Strategie und Portfolioanalyse Erstellen und Überprüfung von globalen Launch Plans von Arzneimitteln, Fprecasting, Modeling Produktentwicklungs- und -lebenszyklus von der Planung von Phase-III-Studien, Markteinführung, HTA Verfahren, Preisverhandlungen, Uptake-Strategien - Schwerpunktindikationen: Immunologie, Alzheimer, Onko, MS, Infektionen, Leberzirrhose

- Launch Audit and Planning - Brand Planning - Market Access - Competitive Pricing - Launch Strategies - Market Research - Global and International Brand Strategies

Market Access, Pricing strategy in the healthcare Industry

Immunbiologie und Bioinformatik